Patients with Cancer Less Likely to Enroll in Clinical Trials Due to COVID-19 Bookmark

Fewer patients with cancer may be willing to enter a clinical trial. This Cancer Network article explains why and offers solutions.

.

NCI-Supported Clinical Trials for Coronavirus Bookmark

This list from the National Cancer Institute outlines many government-supported clinical trials for COVID-19 that may be specifically for cancer survivors.

.

What Cancer Survivorship Can Teach Us About COVID-19 Bookmark

Cancer survivors and (especially long) COVID-19 survivors may have a lot in common, as outlined in this opinion piece from STAT.

.

Patient education: Pancreatic cancer (Beyond the Basics) Bookmark

UpToDate provides an authoritative overview of pancreatic cancer diagnosis and treatment.

.

Treatment of Stage IV- Metastatic or Recurrent Colon Cancer Bookmark

This CancerConnect article summarizes the latest treatment options for stage IV colorectal cancer.

.

Ovarian Cancer Research Alliance: For Patients Bookmark

Living with ovarian cancer may require many adaptations. This respected organization can help. Learn about their comprehensive resources for patients.

.

Renal Cell Carcinoma—An Overview Bookmark

Curated by Editor in Chief George Lundberg, MD, who notes:

There are now many precision oncology treatments for the most common type of kidney cancer, renal cell carcinoma, which represents about 3% of all potentially lethal cancers in America. This summary from Medscape details all the traditional treatment approaches, as well as newer considerations.

.

Efficacy and Safety of Sorafenib Plus Vitamin K Treatment for Hepatocellular CarcinomA: A Phase II, Randomized Study Bookmark

This scientific research paper published in the journal Cancer Medicine reports that the drug sorafenib has shown some effectiveness against hepatocellular carcinoma in a clinical trial, and that adding vitamin K2 enhanced that effectiveness.

.

Targeted Therapy for Hepatocellular Carcinoma Bookmark

This scientific review paper published in the journal Signal Transduction and Targeted Therapy discusses recent research into newer medications that show promise as targeted therapies for some cases of primary hepatocellular carcinoma, following molecular testing.

.

Advice from the Brain Tumor Community Bookmark

NCI-CONNECT shares insights from patients, caregivers, doctors, and advocates with the aim to help you manage your life—regardless of your brain cancer diagnosis.

.